Fujifilm plans to purchase Merck’s biotech-drug makers
Japan’s Fujifilm, has been diversifying into health care, Monday said that it would buy U.S. and British biopharmaceutical businesses from America’s Merck for a reported half a billion U.S. dollars.
The Japanese film and camera maker said that it would purchase all the shares of Diosynth RTP Inc. of the United States and of Britain’s MSD Biologics Ltd. from Merck, with no disclosure of the purchase price.
Fujifilm had agreed to pay about $490 million for the two arms of the Merck BioManufacturing Network, the Nikkei business daily said.
*****************************************************
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.
